Stock listing
KRX:314130 Genome & Co. (지놈앤컴퍼니) 주가
Follow Genome & Co. into a list and get an email when it puts out news.
Share price · KRX:314130
₩2,525.00 KRW -475.00 (-15.8%)
Close on Nov 20, 2026
- Day range
- ₩2,450.00 – ₩2,750.00 KRWNov 20, 2026
- Volume
- 771,112 sharesNov 20, 2026
- Market cap
- ₩114.1B KRWAt the close on Nov 20, 2026 · price × 45.18M shares outstanding
- 52-week range
- ₩2,450.00 – ₩10,180.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩1.75B KRWMedian day 288,532 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:314130 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩2,525.00 | -475.00 | -15.8% | ₩2,750.00 | ₩2,750.00 | ₩2,450.00 | 771,112 | |
| ₩3,000.00 | +80.00 | +2.7% | ₩2,960.00 | ₩3,050.00 | ₩2,850.00 | 171,296 | |
| ₩2,920.00 | -45.00 | -1.5% | ₩2,970.00 | ₩2,995.00 | ₩2,840.00 | 246,538 | |
| ₩2,965.00 | -185.00 | -5.9% | ₩3,180.00 | ₩3,275.00 | ₩2,870.00 | 532,682 | |
| ₩3,150.00 | -125.00 | -3.8% | ₩3,260.00 | ₩3,435.00 | ₩3,135.00 | 205,335 | |
| ₩3,275.00 | -60.00 | -1.8% | ₩3,330.00 | ₩3,350.00 | ₩3,195.00 | 135,229 | |
| ₩3,335.00 | +35.00 | +1.1% | ₩3,330.00 | ₩3,350.00 | ₩3,220.00 | 181,873 | |
| ₩3,300.00 | +110.00 | +3.4% | ₩3,280.00 | ₩3,370.00 | ₩3,160.00 | 162,334 | |
| ₩3,190.00 | +45.00 | +1.4% | ₩3,150.00 | ₩3,290.00 | ₩3,050.00 | 268,435 | |
| ₩3,145.00 | -370.00 | -10.5% | ₩3,315.00 | ₩3,425.00 | ₩3,085.00 | 446,788 | |
| ₩3,515.00 | -95.00 | -2.6% | ₩3,605.00 | ₩3,742.00 | ₩3,455.00 | 199,120 | |
| ₩3,610.00 | +240.00 | +7.1% | ₩3,400.00 | ₩3,640.00 | ₩3,100.00 | 571,038 | |
| ₩3,370.00 | -130.00 | -3.7% | ₩3,490.00 | ₩3,500.00 | ₩3,295.00 | 264,260 | |
| ₩3,500.00 | -5.00 | -0.1% | ₩3,520.00 | ₩3,590.00 | ₩3,435.00 | 146,012 | |
| ₩3,505.00 | -135.00 | -3.7% | ₩3,600.00 | ₩3,830.00 | ₩3,470.00 | 217,243 | |
| ₩3,640.00 | -200.00 | -5.2% | ₩3,935.00 | ₩3,935.00 | ₩3,640.00 | 222,699 | |
| ₩3,840.00 | -60.00 | -1.5% | ₩4,045.00 | ₩4,065.00 | ₩3,795.00 | 252,610 | |
| ₩3,900.00 | +10.00 | +0.3% | ₩3,880.00 | ₩4,115.00 | ₩3,880.00 | 215,159 | |
| ₩3,890.00 | -15.00 | -0.4% | ₩3,910.00 | ₩4,160.00 | ₩3,775.00 | 323,628 | |
| ₩3,905.00 | -110.00 | -2.7% | ₩3,995.00 | ₩3,995.00 | ₩3,830.00 | 216,334 | |
| ₩4,015.00 | -205.00 | -4.9% | ₩4,225.00 | ₩4,225.00 | ₩3,970.00 | 318,036 | |
| ₩4,220.00 | +5.00 | +0.1% | ₩4,430.00 | ₩4,430.00 | ₩4,180.00 | 230,714 | |
| ₩4,215.00 | -125.00 | -2.9% | ₩4,400.00 | ₩4,400.00 | ₩4,100.00 | 321,504 | |
| ₩4,340.00 | -365.00 | -7.8% | ₩4,500.00 | ₩4,695.00 | ₩4,250.00 | 448,004 | |
| ₩4,705.00 | +485.00 | +11.5% | ₩4,220.00 | ₩4,725.00 | ₩4,105.00 | 418,267 | |
| ₩4,220.00 | -530.00 | -11.2% | ₩4,650.00 | ₩4,650.00 | ₩4,170.00 | 680,224 | |
| ₩4,750.00 | -130.00 | -2.7% | ₩4,925.00 | ₩5,100.00 | ₩4,690.00 | 329,019 | |
| ₩4,880.00 | -290.00 | -5.6% | ₩5,130.00 | ₩5,150.00 | ₩4,640.00 | 815,504 | |
| ₩5,170.00 | -300.00 | -5.5% | ₩5,480.00 | ₩5,480.00 | ₩5,120.00 | 356,722 | |
| ₩5,470.00 | +150.00 | +2.8% | ₩5,290.00 | ₩5,700.00 | ₩5,060.00 | 643,488 | |
| ₩5,320.00 | -560.00 | -9.5% | ₩5,870.00 | ₩5,870.00 | ₩5,180.00 | 866,590 | |
| ₩5,880.00 | +380.00 | +6.9% | ₩5,630.00 | ₩5,930.00 | ₩5,500.00 | 763,614 | |
| ₩5,500.00 | +110.00 | +2.0% | ₩5,390.00 | ₩5,620.00 | ₩5,240.00 | 566,287 | |
| ₩5,390.00 | +290.00 | +5.7% | ₩5,110.00 | ₩5,420.00 | ₩5,000.00 | 454,458 | |
| ₩5,100.00 | +610.00 | +13.6% | ₩4,550.00 | ₩5,310.00 | ₩4,500.00 | 1,099,387 | |
| ₩4,490.00 | -155.00 | -3.3% | ₩4,665.00 | ₩4,665.00 | ₩4,380.00 | 406,163 | |
| ₩4,645.00 | -190.00 | -3.9% | ₩4,800.00 | ₩4,800.00 | ₩4,545.00 | 477,705 | |
| ₩4,835.00 | +605.00 | +14.3% | ₩4,230.00 | ₩4,985.00 | ₩4,150.00 | 1,394,937 | |
| ₩4,230.00 | +240.00 | +6.0% | ₩3,965.00 | ₩4,260.00 | ₩3,905.00 | 807,851 | |
| ₩3,990.00 | +595.00 | +17.5% | ₩3,470.00 | ₩4,110.00 | ₩3,465.00 | 1,773,248 | |
| ₩3,395.00 | -120.00 | -3.4% | ₩3,455.00 | ₩3,515.00 | ₩2,925.00 | 2,121,833 | |
| ₩3,515.00 | +185.00 | +5.6% | ₩3,345.00 | ₩3,595.00 | ₩3,310.00 | 383,702 | |
| ₩3,330.00 | -75.00 | -2.2% | ₩3,410.00 | ₩3,525.00 | ₩3,300.00 | 300,849 | |
| ₩3,405.00 | +230.00 | +7.2% | ₩3,285.00 | ₩3,475.00 | ₩3,185.00 | 968,364 | |
| ₩3,175.00 | -75.00 | -2.3% | ₩3,320.00 | ₩3,320.00 | ₩3,120.00 | 90,516 | |
| ₩3,250.00 | -50.00 | -1.5% | ₩3,255.00 | ₩3,340.00 | ₩3,210.00 | 110,363 | |
| ₩3,300.00 | -70.00 | -2.1% | ₩3,345.00 | ₩3,355.00 | ₩3,245.00 | 173,838 | |
| ₩3,370.00 | +85.00 | +2.6% | ₩3,330.00 | ₩3,425.00 | ₩3,255.00 | 92,230 | |
| ₩3,285.00 | -160.00 | -4.6% | ₩3,445.00 | ₩3,495.00 | ₩3,285.00 | 137,131 | |
| ₩3,445.00 | +10.00 | +0.3% | ₩3,445.00 | ₩3,500.00 | ₩3,355.00 | 119,852 | |
| ₩3,435.00 | +85.00 | +2.5% | ₩3,400.00 | ₩3,500.00 | ₩3,350.00 | 117,839 | |
| ₩3,350.00 | -130.00 | -3.7% | ₩3,515.00 | ₩3,655.00 | ₩3,335.00 | 172,303 | |
| ₩3,480.00 | -330.00 | -8.7% | ₩3,655.00 | ₩3,760.00 | ₩3,480.00 | 230,267 | |
| ₩3,810.00 | +55.00 | +1.5% | ₩3,755.00 | ₩3,875.00 | ₩3,605.00 | 255,370 | |
| ₩3,755.00 | -60.00 | -1.6% | ₩3,795.00 | ₩3,795.00 | ₩3,500.00 | 233,964 | |
| ₩3,815.00 | -170.00 | -4.3% | ₩3,990.00 | ₩4,020.00 | ₩3,800.00 | 293,314 | |
| ₩3,985.00 | -60.00 | -1.5% | ₩4,045.00 | ₩4,100.00 | ₩3,950.00 | 188,452 | |
| ₩4,045.00 | -30.00 | -0.7% | ₩4,075.00 | ₩4,130.00 | ₩3,990.00 | 328,849 | |
| ₩4,075.00 | -165.00 | -3.9% | ₩4,235.00 | ₩4,235.00 | ₩3,950.00 | 283,749 | |
| ₩4,240.00 | +35.00 | +0.8% | ₩4,230.00 | ₩4,365.00 | ₩4,150.00 | 208,829 | |
| ₩4,205.00 | -210.00 | -4.8% | ₩4,275.00 | ₩4,475.00 | ₩4,150.00 | 271,152 | |
| ₩4,415.00 | +185.00 | +4.4% | ₩4,360.00 | ₩4,520.00 | ₩4,160.00 | 324,927 |
Splits
1 split · KRX:314130 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split |
- Ticker
- KRX:314130
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Latest news
Genome & Co. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in all · newest May 16, 2025 · oldest 2025
- Decks
- 2 decks · latest November 2025
Valuation
EV/sales 2.0× against a median of 30.4×: 4th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩49.77B KRW
- P/E
- Loss
- EV/sales
- 2.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.6×
- Gross margin
- 54.5%
- Operating margin
- −119.3%
- Net margin
- −169.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Genome & Co. · KRX:314130 | US$84.78M | US$36.99M | n/a | 2.0× | n/a | 1.6× | −169.1% | 0.0× | n/a |
| Upstream Bio, Inc. · NASDAQ:UPB | US$87.15M | −US$119.4M | n/a | −41.6× | n/a | 0.4× | n/a | 0.0× | 1.95 |
| Senhwa Biosciences Inc · TPEX:6492 | US$86.77M | US$67.44M | n/a | 2,117× | n/a | 4.6× | n/a | 0.0× | n/a |
| Bioceltix SA · GPW:BCX | US$86.32M | US$72.38M | n/a | n/a | n/a | 5.6× | n/a | 0.0× | n/a |
| Perspective Therapeutics, Inc. · AMEX:CATX | US$86.05M | −US$114.1M | n/a | −570× | n/a | 0.3× | n/a | 0.0× | 1.47 |
| Pharmosa Biopharm Inc. · TPEX:6875 | US$86.04M | US$62.27M | n/a | 38.5× | n/a | 2.1× | −658.1% | 0.1× | n/a |
| Formosa Pharmaceuticals, Inc. · TWSE:6838 | US$85.44M | US$48.52M | n/a | 30.4× | n/a | 2.0× | −361.4% | 0.0× | n/a |
| Anixa Biosciences, Inc. · NASDAQ:ANIX | US$84.82M | US$70.96M | n/a | n/a | n/a | 5.9× | n/a | 0.0× | 1.45 |
| BetterLife Pharma Inc. · CSE:BETR | US$84.03M | US$83.37M | n/a | n/a | n/a | n/a | n/a | n/a | 1.14 |
| Shine-On Biomedical Co., Ltd. · TPEX:6926 | US$83.56M | US$59.02M | n/a | 64.8× | n/a | 3.5× | −367.6% | 0.0× | n/a |
| Rallybio Corporation · NASDAQ:RLYB | US$83.29M | −US$7.40M | 3.1× | −17.1× | n/a | 0.9× | n/a | 0.0× | 0.58 |
| Median of the others | US$85.74M | US$60.65M | 3.1× | 30.4× | 2.1× | −367.6% | 0.0× | 1.45 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2025) | Investor deck | 42 slides | November 2025 |
| Investor Presentation (June 2025) | Investor deck | 35 slides | June 2025 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 24.6B | 27.7B | 14.3B | 14.1B | 451.2M |
| Cost of revenue | 11.2B | 12.1B | 10.2B | 8.49B | 77.0M |
| Gross profit | 13.4B | 15.7B | 4.06B | 5.60B | 374.2M |
| Research and development | 11.9B | 13.4B | 25.7B | 36.8B | 21.3B |
| Selling, general and administrative | 16.1B | 22.0B | 28.7B | 19.7B | 6.96B |
| Operating income | -29.2B | -32.6B | -57.4B | -57.5B | -36.1B |
| Depreciation and amortization | 6.67B | 4.47B | 5.31B | 4.61B | 2.59B |
| EBITDA | -22.6B | -28.1B | -52.1B | -52.9B | -33.5B |
| Interest expense | 4.72B | 3.54B | 1.74B | 175.0M | 54.9M |
| Income before tax | -8.67B | -28.2B | -51.9B | -58.0B | -36.0B |
| Net income | -6.43B | -20.1B | -47.5B | -51.8B | -34.1B |
| Earnings per share, basic | -184.22 | -647.65 | -1,611.73 | -1,839.34 | -1,212.72 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 15.6B | 65.5B | 56.4B | 72.2B | 36.0B |
| Short-term investments | 21.2B | 11.7B | 26.1B | 29.3B | 41.1B |
| Receivables | 1.86B | 3.74B | 2.05B | 2.79B | 759.2M |
| Inventory | 5.98B | 5.77B | 3.57B | 2.24B | 1.33B |
| Current assets | 52.3B | 91.9B | 97.0B | 116.9B | 81.8B |
| Property, plant and equipment | 27.9B | 34.6B | 21.5B | ||
| Goodwill | 11.1B | 14.1B | 14.1B | 16.5B | 16.5B |
| Total assets | 145.0B | 147.3B | 162.1B | 173.0B | 137.2B |
| Accounts payable | 509.1M | 481.2M | 340.2M | 205.2M | 321.4M |
| Current liabilities | 22.8B | 29.8B | 28.2B | 11.1B | 9.83B |
| Long-term debt | 9.00B | 9.64B | |||
| Total liabilities | 30.4B | 99.0B | 99.6B | 75.7B | 23.8B |
| Shareholders' equity | 105.8B | 48.3B | 62.4B | 97.3B | 92.7B |
| Shares outstanding | 34.9M | 31.1M | 29.5M | 28.2M | 28.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | -18.4B | -7.61B | -31.0B | -36.0B | -26.2B |
| Capital spending | -497.7M | -4.19B | -19.0B | -7.28B | -3.38B |
| Free cash flow | -18.9B | -20.5B | -51.3B | -50.8B | -29.5B |
| Cash from investing | 11.6B | -15.4B | -6.38B | ||
| Cash from financing | 5.25B | 30.6B | 78.6B | ||
| Share buybacks | -54.2B | 33.8M | 81.5M | 80.2B | |
| Change in cash | -50.0B | 9.19B | -15.9B | 36.2B | -67.9B |
Cap table
Built by 6ix from Genome & Co.’s releases
- Common shares
- 45,178,153
- Fully diluted
- 45,178,153
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 45,178,153 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 45,178,153 |
Log in to ask 6ix AI your own questions about Genome & Co.